Archangel Ventures Research
Investment Thesis
Archangel Ventures is a Melbourne-based, pre-seed and seed-stage venture capital firm founded in 2020 by Ben Armstrong, Rayn Ong, and Quentin Wallace. The firm positions itself as a "first-cheque" investor, arguing that pre-seed investing isn't just about capital but about trust, speed, and conviction. Its stated mission is to back "exceptional founders solving the biggest problems" and to help build "generational companies" from their earliest, most fragile stages. The firm describes itself as offering empathy-driven support and candid business advice rather than cheerleading, and emphasizes a fast, low-friction decision process: "No unnecessary meetings. No dragging out decisions."
Sector Focus
Archangel describes itself as sector-agnostic and "generalist by design," backing founders "who move the world forward" across industries rather than committing to a narrow vertical thesis. In practice, the portfolio skews toward AI-native software, healthtech, fintech, consumer, supply chain/logistics, and deeptech (robotics/drones), reflecting broad exposure to Australian technology-driven startups rather than a single specialization.
Stage Focus
The firm deploys the majority of its capital at pre-seed, with continued participation in seed and select follow-on rounds as portfolio companies mature. It frequently serves as the first institutional capital into a company.
Check Size
Publicly aggregated investor-database sources put Archangel's initial check size in the range of roughly $20K to $500K at formation stage, consistent with a first-cheque, pre-seed-led strategy. The firm also participates in later, larger rounds for existing portfolio companies (e.g., Heidi Health's $65M Series B) as a continuing investor rather than a lead.
Lead Tendency
Archangel typically leads or is among the first capital into pre-seed rounds, consistent with its "first-cheque investor" positioning. In later-stage follow-on rounds for existing portfolio companies, it participates alongside other investors rather than leading (e.g., Heidi Health's Series B was led by Point72 Private Investments, with Archangel continuing to participate as an existing shareholder).
Recent Activity
Archangel is currently raising its 2026 Fund (structured as an ESVCLP), targeting roughly $40M to back Australian founders at pre-seed and seed, with managing partner Ben Armstrong stating in February 2026 that the firm had already locked in roughly half the target from existing investors. This follows a ~$40M 2022 fund raised from about 150 wholesale investors. Recent portfolio activity includes an August 2026 investment in Sophiie AI's AUD $5M seed round (alongside Admiralty Capital Group, Antler, Gandel Invest, and Aussie Angels) and continued participation in Heidi Health's $65M Series B (October 2025, led by Point72 Private Investments), where Archangel also organized a rare "community round" allowing Heidi's own platform users to co-invest.
Portfolio Highlights
Archangel's portfolio spans 70+ disclosed companies and 150+ founders backed to date, including notable names such as Heidi Health (AI clinical scribe/care platform, now valued near $465M after its Series B), Relevance AI, Pearler (fintech/wealth app), Sendle (supply chain/shipping), MagicBrief (ad/mar-tech), Vively (healthtech), Mutinex, Emesent and Aerotruth (deeptech/robotics), Sophiie AI (AI operating system for trades businesses), and Heaps Normal (consumer, non-alcoholic beer). The firm reports 50+ pre-seed investments and 20+ follow-on investments to date, with a small number of exits.
Team
- Ben Armstrong, Managing Partner — Co-founder; 15 years investing in VC across Australia and the US with multiple exits; ex-Telstra Ventures; prolific angel investor (~250 investments) and former founder; named Investor of the Year at the 2025 Governor of Victoria Startup Awards.
- Rayn Ong, Partner — Co-founder; active angel investor with 100+ early-stage investments; known for sharp sourcing instincts.
- Andrew Cicutto, Partner — Former founder and investment banker with active early-stage investing, operating, and dealmaking experience.
- Quentin Wallace, Venture Partner — Co-founder; Startmate MVP; former lawyer and General Counsel at Culture Amp; former startup founder in music and logistics.
- Thea Ngo, Senior Investment Associate — Ex-PwC Strategy& (New York); Southeast Asia venture builder; creator of "Founders In Motion."
- Grace Liang, Head of Investor Relations and Operations — 12+ years in fund governance and complex investment structures; experienced board director for scaling fund platforms.
The firm also draws on a small advisory bench spanning telecom (Ashe-lee Jegathesan, COO at Uniti Group), institutional investing (Lilian Fang, Senior Portfolio Manager at AustralianSuper), and asset management (Suzanne Branton, CIO at CareSuper).
Decision Process
Archangel operates as a partnership (Ben Armstrong, Rayn Ong, and Andrew Cicutto as investing partners, with Quentin Wallace as venture partner) and emphasizes a deliberately fast, low-friction process, positioning speed and directness as a differentiator versus larger, committee-driven funds.
Founder Preferences
The firm favors founders tackling large, ambitious problems at the earliest, idea-stage phase of company formation, valuing candor and resilience over polish. Its tagline, "Small Groups of Motivated People Can Change The World," reflects a preference for small, high-conviction founding teams.
Geographic Focus
Archangel is headquartered in Melbourne, Australia, and primarily backs Australian founders, with its 2026 Fund materials framed around "Day One. Australian roots. Global Ambition." The firm also engages selectively with founders in New Zealand, Southeast Asia, and has ties to entrepreneurs in Canada, Singapore, and the United States.